Casodex, Bicalutamide News

Main Category: Prostate / Prostate Cancer Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 24 Sep 2009 - 2:00 PDT Medivation, Inc.

UroToday.com - Use of an anti-androgen with castration for the treatment of prostate cancer is referred to as combined androgen blockage .

UroToday.com - Use of an anti-androgen with castration for the treatment of prostate cancer is referred to as combined androgen blockage .

PRINCETON,A N.J. Novartisa s generic drug arm has launched a version of an AstraZeneca drug.

PITTSBURGH The Food and Drug Administration has approved Mylana s generic version of a drug for treating prostate cancer.

NORTH WALES,A Pa. Teva has introduced a generic version of a drug used to treat prostate cancer, the Israeli drug makera s U.S. subsidiary announced Monday.

Mumbai, July 7, 2009: Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for an Abbreviated New Drug Application for generic Casodex , bicalutamide tablets.

Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the FDA for its Abbreviated New Drug Application for Bicalutamide Tablets, 50 mg.

Companies mentioned in this article: Caraco Pharmaceutical Laboratories, Ltd. DETROIT , /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd.

Findings Presented at American Society of Clinical Oncology 2009 Annual Meeting and Included in Best of ASCO Educational Program -- SAN FRANCISCO, June 2 /PRNewswire-FirstCall/ -- Medivation, Inc.